Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Oxford BioDynamics plc (OBD) Ordinary 1p Shares

Sell:105.00p Buy:108.00p 0 Change: 4.50p (4.05%)
Market closed Prices as at close on 10 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:105.00p
Buy:108.00p
Change: 4.50p (4.05%)
Market closed Prices as at close on 10 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:105.00p
Buy:108.00p
Change: 4.50p (4.05%)
Market closed Prices as at close on 10 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Oxford BioDynamics Plc is a biotechnology company, which is engaged in biomarker research and development. The Company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. Its geographical segments include UK and Malaysia. Its EpiSwitch is an industrial platform for the discovery, evaluation, validation and monitoring of a class of epigenetic biomarkers known as chromosome conformation signatures (CCSs). EpiSwitch is a biomarker technology platform that facilitates pharmaceutical and biotechnology companies in their therapeutic development programs and the development of companion diagnostics. The EpiSwitch technology has validated biomarkers in a range of diseases, including Alzheimer's disease, breast cancer, ulcerative colitis and liver cancer. Its service offering includes predictive biomarkers, prognostic biomarkers, residual disease monitoring biomarkers, diagnostic biomarkers and companion diagnostic biomarkers.

Contact details

Address:
26 Beaumont Street
OXFORD
OX1 2NP
United Kingdom
Telephone:
+44 (01865) 518910
Website:
www.oxfordbiodynamics.com/

Important dates

Future events
There are no future events available.
Past events
Final results 10 December 2019 10/12/19
Interim results 28 May 2019 28/05/19
AGM 14 March 2019 14/03/19
Annual report 25 January 2019 25/01/19

General stock information

EPIC:
OBD
ISIN:
GB00BD5H8572
Market cap:
£98.11 million
Shares in issue:
92.56 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Christian Millar
    Chief Executive Officer, Executive Director
  • Paul Stockdale
    Chief Financial Officer, Executive Director
  • Aroul Ramadass
    Chief Technology Officer
  • Alexandre Akoulitchev
    Chief Scientific Officer, Executive Director
  • Jayne Green
    Laboratory Project Manager
  • Ewan Hunter
    Director - Business Development
  • Lim Chun Ren
    Director, Asia
  • Howard Womersley
    Director - Platform Development
  • Susan Steven
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.